Special notice
GloMax(R) Discover System and Dual Injectors with Pumps
NOI-CC-OLAO-26-007847
National Institutes of Health, National Institutes of Health - CC. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
July 23, 2026 at 12:00 PM EDT
Closed 55 days ago. Posted July 8, 2026. Scheduled to archive August 7, 2026.
Description
As published on SAM.gov.
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Promega Corporation.
Acquisition Description: Order is associated with research investigations that are central to the mission of the Clinical Center and the NIH. Failure to fulfill would jeopardize time-sensitive experiments & would waste already-invested funds. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.
All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-007847) by 12:00 PM eastern standard time on 07/23/2026 to:
valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 8, 2026
Special notice
Due July 23, 2026 at 12:00 PM EDT. SAM.gov, notice 3345142bf4f64104949bcca75baf2e28
Also open from this buyer
- ASIT.TO 1 year software support from ArgonSoft (Notice of Intent to sole source)PresolicitationNAICS 513210MarylandNOI-CC-26-000808Closes in 50 daysNov 5